Adoptive Cell Immunotherapy in Relapse/Refractory Epstein–Barr Virus-Driven Post-Transplant Lymphoproliferative Disorders
Post-transplant lymphoproliferative disorders (PTLD) represent a life-threatening complication following solid organ transplantation (SOT) and allogeneic hematopoietic stem cell transplantation (allo-HSCT), particularly in patients with relapsed or refractory (R/R) disease, where therapeutic options...
Saved in:
| Main Authors: | Martina Canichella, Paolo de Fabritiis |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Antibodies |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4468/14/2/47 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analysis of risk factors for Epstein–Barr virus reactivation and progression to post-transplant lymphoproliferative disorder in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation
by: Lanzhou Jia, et al.
Published: (2025-07-01) -
A case of coexistence of hydroa vacciniforme-like lymphoproliferative disorder and Epstein-Barr virus pneumonia
by: Wei Zhang, MD, PhD, et al.
Published: (2025-09-01) -
Epstein-Barr virus infection following allogeneic hematopoietic stem cell transplantation in the era of letermovir for cytomegalovirus prophylaxis
by: Jingtao Huang, et al.
Published: (2025-05-01) -
Central nervous system posttransplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation successfully treated with combination therapy of acalabrutinib and immunochemotherapy: A case report and literature review
by: Peihao Zheng, et al.
Published: (2025-02-01) -
Characteristics of Post-Transplant Lymphoproliferative Disorder in Adult Liver Transplant Recipients—A Single Centre Experience
by: Katrina Tan, et al.
Published: (2025-06-01)